Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

痛い目という痛い目.

S Lightman, H M Towler

    Lancet (London, England)
    |February 3, 1996
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Feasibility of salivary cortisol collection in patients and companions attending dementia diagnostic meetings in memory clinics.

    BMC research notes·2021
    Same author

    Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.

    European journal of endocrinology·2019
    Same author

    Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

    Annals of the rheumatic diseases·2014
    Same author

    Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

    Ocular immunology and inflammation·2012
    Same author

    Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis.

    Ocular immunology and inflammation·2012
    Same author

    Visual prognosis in Behçet's disease.

    Ocular immunology and inflammation·2012
    Same journal

    Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

    Lancet (London, England)·2026
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

    Lancet (London, England)·2026
    関連記事をすべて見る